Result of AGM

Impact Healthcare REIT PLC
17 May 2023
 

17 May 2023

Impact Healthcare REIT plc

("Impact" or the "Company")

Result of 2023 Annual General Meeting

The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, announces that at the Company's 2023 Annual General Meeting held today, all resolutions proposed at the AGM were voted on and passed by a poll by the Company's shareholders and the results of the poll, including the proxy votes received, are set out below.

 

Resolutions 1 to 12 (inclusive) were proposed as ordinary resolutions and resolutions 13 to 16 (inclusive) were proposed as special resolutions.

 


Resolution

Votes For*

%

Votes Against

%

Total votes validly cast

Total votes cast as % of issued share capital

Votes Withheld **

1

Receive the Annual Report and Financial Statements Year 31 December 2022

281,210,111

100.00%

0

0.00%

281,210,111

67.86%

226,521

2

Approve the directors' remuneration report

281,154,070

99.96%

115,981

0.04%

281,270,051

67.88%

166,581

3

Approve the Company's Dividend Policy

281,387,092

100.00%

0

0.00%

281,387,092

67.91%

49,540

4

Re-elect Rosemary Boot as a director

278,046,424

98.81%

3,343,574

1.19%

281,389,998

67.91%

46,634

5

Re-elect Philip Hall as a director

278,055,966

98.81%

3,334,922

1.19%

281,390,888

67.91%

45,744

6

Re-elect Amanda Aldridge as a director

279,416,802

99.30%

1,974,086

0.70%

281,390,888

67.91%

45,744

7

Re-elect Chris Santer as a director

279,425,480

99.30%

1,965,408

0.70%

281,390,888

67.91%

45,744

8

Elect Simon Laffin as a director

281,388,218

100.00%

2,670

0.00%

281,390,888

67.91%

45,744

9

To re-appoint BDO LLP as the Company's auditor

276,383,577

100.00%

5,434

0.00%

276,389,011

66.70%

5,047,621

10

To authorise the board of directors to determine the auditors remuneration

281,388,454

100.00%

2,434

0.00%

281,390,888

67.91%

45,744

11

To authorise the Directors to allot shares under section 551 Companies Act 2006

281,279,879

99.96%

104,277

0.04%

281,384,156

67.91%

48,680

12

Subject to the passing of resolution 11, to authorise the Directors to allot additional shares under section 551 Companies Act 2006

281,251,968

99.95%

138,920

0.05%

281,390,888

67.91%

45,744

13

Subject to the passing of resolution 11, to disapply statutory pre-emption rights under section 570 Companies Act 2006

280,589,017

99.72%

798,935

0.28%

281,387,952

67.91%

48,680

14

Subject to the passing of resolution 12, to disapply statutory pre-emption rights under section 570 Companies Act 2006

274,009,998

97.38%

7,377,954

2.62%

281,387,952

67.91%

48,680

15

To authorise the Company to make market purchase of its own ordinary shares

273,102,300

97.07%

8,240,537

2.93%

281,342,837

67.90%

93,795

16

To permit general meetings to be called on 14 days' notice

274,651,335

97.60%

6,739,553

2.40%

281,390,888

67.91%

45,744

 

Every shareholder has one vote for every Ordinary Share held. As at close of business on 17 May 2023, the share capital of the Company consisted of 414,368,169 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury.

 

In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

* Includes discretionary votes.

** A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Maitland/AMO



JTC (UK) Limited - Company Secretary

Susan Fadil

0207 409 0181

Impact.CoSec@jtcgroup.com

 


Maitland/AMO (Communications Adviser)

James Benjamin

07747 113 930

impacthealth-maitland@maitland.co.uk

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

NOTES

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.

 

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

 

The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.

 

On this basis, the target total dividend for the year ending 31 December 2023 is 6.77 pence per share(3), a 3.53% increase over the 6.54 pence in dividends paid or declared per ordinary share for the year ended 31 December 2022.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

 

(3)       This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100